Self-funded employer groups face an overwhelming number of challenges in 2023 and beyond when tasked with controlling pharmacy costs, including an emerging anti-obesity pipeline,…
Specialty drug management remains a top concern for health payers, including managed care organizations and employers. The 2023 State of Specialty Spend and Trend Report…
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This proprietary research provides detailed intelligence to support employers,…
Value-based care and contracting is receiving substantial attention across the health care landscape as a tool for improving patient care and managing costs, and pharmaceuticals…
Special Thanks to Our Sponsor: Specialty drug management remains a top concern for health payers, including managed care organizations and employers. The 2023 State of…
Who would have imagined one of the hottest online trends would be pharmaceuticals for weight loss? Social media and commercials are flooded with advertisements for…
May 10, 2023 12:45 PM Central Time PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This proprietary…
Today is a milestone in the world of biosimilars, as the first Humira® biosimilar Amjevita™ (adalimumab-atto), manufactured by Amgen, has launched in the U.S. Will it have…
Get the Full Analysis of the Big 3 Formulary Changes: 2023 Formulary Changes: CVS Health 2023 Formulary Changes: Express Scripts 2023 Formulary Changes: OptumRx As…
Migraines represent the world’s third most prevalent illness. A new class of drugs called calcitonin gene-related peptide (CGRP) inhibitors entered the market in 2018. Since…